Dr. Fletcher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
75 Francis St
Brigham And Womens Hospital Department Of Pathology
Boston, MA 02115Phone+1 617-732-7883- Is this information wrong?
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1986 - 1988
- Boston University Medical CenterFellowship, Hematology and Medical Oncology, 1985 - 1986
- Boston University Medical CenterResidency, Internal Medicine, 1981 - 1985
- Boston University School of MedicineClass of 1981
Certifications & Licensure
- MA State Medical License 1985 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Medical Genetics and Genomics Clinical Cytogenetics
Publications & Presentations
PubMed
- 7 citationsE3 ubiquitin ligase Atrogin-1 mediates adaptive resistance to KIT-targeted inhibition in gastrointestinal stromal tumor.Alfonso García-Valverde, Jordi Rosell, Sergi Sayols, David Gómez-Peregrina, Daniel F Pilco-Janeta, Iván Olivares-Rivas, Enrique de Álava, Joan Maurel, Jordi Rubió-Casa...> ;Oncogene. 2021 Oct 7
- 18 citationsE3 ligase MKRN3 is a tumor suppressor regulating PABPC1 ubiquitination in non-small cell lung cancer.Ke Li, Xufen Zheng, Hua Tang, Yuan-Sheng Zang, Chunling Zeng, Xiaoxiao Liu, Yanying Shen, Yuzhi Pang, Simin Wang, Feifei Xie, Xiaojing Lu, Yuxiang Luo, Zhang Li, Wenbo...> ;The Journal of Experimental Medicine. 2021 Aug 2
- 8 citationsYWHAE-NUTM2 oncoprotein regulates proliferation and cyclin D1 via RAF/MAPK and Hippo pathwaysWen-Bin Ou, Meijun Z. Lundberg, Shuihao Zhu, Nacef Bahri, Anastasios Kyriazoglou, Liangliang Xu, Ting Chen, Adrián Mariño-Enríquez, Jonathan A. Fletcher> ;Oncogenesis. 2021 May 4
- Join now to see all
Journal Articles
- LMTK3 Is Essential for Oncogenic KIT Expression in KIT-Mutant GIST and MelanomaJonathan A Fletcher, William H Fleming, Nature
Press Mentions
- Demetri’s Team Approach Translates into Success in Sarcoma ResearchFebruary 10th, 2016
Grant Support
- Core--Molecular CytogeneticsNational Cancer Institute2000–2002
- Translocation Of 8-13 In Stem-Cell Leukemia/LymphomaNational Cancer Institute1997–1999
- Tumor Suppressor Loci In MesotheliomaNational Cancer Institute1996–1998
- Molecular Cytogenetics Of Solid TumorsNational Cancer Institute1990–1994
Hospital Affiliations
- Brigham and Women's HospitalBoston, Massachusetts
- Dana-Farber Cancer InstituteBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: